Amicus Therapeutics, Inc. (FOLD)

Amicus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	246.99	148.81	245.2	163.24	142.84
Short-Term Investments	39.21	144.78	237.3	320.03	309.9
Cash & Cash Equivalents	286.2	293.6	482.5	483.27	452.74
Cash Growth	-2.52%	-39.15%	-0.16%	6.74%	-10.20%
Receivables	87.63	66.2	52.67	46.92	33.28
Inventory	59.7	23.82	26.82	19.56	14.04
Other Current Assets	49.53	40.21	34.85	29.72	20.01
Total Current Assets	483.06	423.82	596.83	579.47	520.07
Property, Plant & Equipment	57.98	60.31	63.08	67.16	81.02
Goodwill and Intangibles	218.29	220.8	197.8	197.8	197.8
Other Long-Term Assets	18.55	19.24	47.43	42.1	51.32
Total Long-Term Assets	294.82	300.35	308.31	307.05	330.13
Total Assets	777.88	724.17	905.14	886.52	850.21
Accounts Payable	15.12	36.83	40.41	42.89	44.4
Current Debt	8.32	8.55	7.41	6.87	7.19
Other Current Liabilities	144.25	93.64	98.15	79.92	77.22
Total Current Liabilities	167.69	139.02	145.98	129.68	128.81
Long-Term Debt	436.74	443.57	432.72	434.86	203.04
Other Long-Term Liabilities	13.28	18.53	19.08	35.61	41.93
Total Long-Term Liabilities	450.02	462.1	451.8	470.46	244.97
Total Liabilities	617.71	601.12	597.77	600.14	373.78
Total Debt	445.06	452.12	440.13	441.73	210.23
Debt Growth	-1.56%	2.72%	-0.36%	110.12%	-34.66%
Retained Earnings	-2,684.07	-2,532.49	-2,295.92	-2,045.46	-1,768.61
Comprehensive Income	5.24	-12.11	4.98	8.23	2.83
Shareholders' Equity	160.17	123.05	307.37	286.38	476.43
Net Cash / Debt	-158.86	-158.53	42.37	41.54	242.52
Net Cash / Debt Growth	-	-	1.99%	-82.87%	32.95%
Net Cash Per Share	-0.54	-0.55	0.16	0.16	1.01
Working Capital	315.37	284.8	450.86	449.79	391.26
Book Value Per Share	0.54	0.43	1.13	1.11	1.98

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).